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Abstract
A total of 318 Escherichia coli isolates obtained from different food-producing animals affected with colibacillosis
between 2001 and 2006 were subjected to phylogenetic analysis: 72 bovine isolates, 89 poultry isolates and 157
porcine isolates. Overall, the phylogenetic group A was predominant in isolates from cattle (36/72, 50%) and pigs
(101/157, 64.3%) whereas groups A (44/89, 49.4%) and D (40/89, 44.9%) were predominant in isolates from poultry.
In addition, group B2 was not found among diseased food-producing animals except for a poultry isolate. Thus,
the phylogenetic group distribution of E. coli from diseased animals was different by animal species. Among the
318 isolates, cefazolin resistance (minimum inhibitory concentrations: ≥32 μg/ml) was found in six bovine isolates,
29 poultry isolates and three porcine isolates. Of them, 11 isolates (nine from poultry and two from cattle)
produced extended spectrum b-lactamase (ESBL). The two bovine isolates produced blaCTX-M-2, while the nine
poultry isolates produced blaCTX-M-25 (4), blaSHV-2 (3), blaCTX-M-15 (1) and blaCTX-M-2 (1). Thus, our results showed that
several types of ESBL were identified and three types of b-lactamase (SHV-2, CTX-M-25 and CTX-M-15) were
observed for the first time in E. coli from diseased animals in Japan.
Keywords: Escherichia coli, food-producing animals, cephalosporin resistance, extended spectrum b?β?-lactamase,
AmpC b?β?-lactamase, phylogenetic grouping
Findings
Pathogenic Escherichia coli is the causative agent of coli-
bacillosis that brings severe clinical sighs such as diar-
rhea, meningitis and sepsis in domestic animals. E. coli
can be divided into four phylogenetic groups using mul-
tiplex PCR method [1]. Several authors have analyzed
the distribution of the main phylogenetic groups among
E. coli s t r a i n si s o l a t e df r o mh u m a na n da n i m a l s .E x t r a -
intestinal pathogenic E. coli usually belongs to groups
B2 and D, while the commensal strains are groups A
and B1 in humans [2]. In healthy food-producing ani-
mals, a predominant distribution of group B1 was
reported in E. coli from cattle, while group A was pre-
dominantly prevalent in pigs and chickens [3-5]. On the
contrary, although predominant phylogenetic groups
were reported in E. coli from diseased poultry [6-8], lit-
tle information regarding to diseased cattle and pigs was
available.
Antimicrobial agents have been widely used for treat-
ment of colibacillosis in domestic animals. Antimicrobial
resistance is more frequently found in E. coli isolates
from diseased animals than apparently healthy animals
[9]. Increases in cephalosporin-resistant E. coli in
domestic animals have been a significant worldwide
concern including Japan. Extended-spectrum b-lacta-
mase (ESBL)-producing isolates of E. coli were identified
in domestic animals around 2000 in Japan [10,11]. The
third and greater generation cephalosporin antibiotics
are clinically important antimicrobial agents in human
and animal medicines. Such agents are approved to treat
bacterial diseases in cattle and pigs and not licensed for
enhancing animal growth in Japan. However, cephalos-
porin-resistant E. coli has been identified in isolates
from not only cattle and pigs but also poultry in Japan
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any medium, provided the original work is properly cited.[10,12]. At present the reason for the prevalence of
cephalosporin-resistant E. coli in poultry is unclear.
In the present study, we determined the distribution
of phylogenetic groups in E. coli from food-producing
animals affected with colibacillosis in Japan. In addition,
we examined the characteristics of cephalosporin-resis-
tant isolates of E. coli from the diseased animals.
A total of 318 E. coli isolates from different animals
affected with colibacillosis between 2001 and 2006
throughout Japan were used in this study: 72 bovine iso-
lates, 89 poultry isolates and 157 porcine isolates in 23,
20 and 28 prefectures, respectively, located from north
to south Japan. All the strains were stored in 10%
skimmed milk at -80°C until use. The phylogenetic
grouping was performed by multiplex PCR as described
by Clermont et al. [1].
The minimum inhibitory concentration (MIC) of cefa-
zolin (CEZ) was determined by an agar dilution method
in accordance with the guidelines of the Clinical Labora-
tory Standards Institute (CLSI) [13,14]. The MIC of
some of the isolates to CEZ was previously determined
[15]. Susceptibilities of CEZ-resistant isolates to several
b-lactamase antibiotics, cefpodoxime, cefotaxime, cefta-
zidime, aztreonam, imipenem and meropenem were
tested according to the CLSI guideline [13,14] using the
commercially available broth microdilution test (Eiken
C o .L T D ,T o k y o ,J a p a n ) .E. coli ATCC 25922 and Pseu-
domonas aeruginosa ATCC 27853 were used as quality
controls for MIC determination. The Chi-square test
was performed on the antimicrobial susceptibility and
t h ep h y l o g e n e t i cs u b g r o u pd a t a .T h er e s i s t a n c er a t e si n
each phylogenetic group were compared with those in
the overall strains tested. For each comparison, a P
value of < 0.05 was considered to denote significant
differences.
A double-disk synergy test for detection of ESBLs was
performed using clavulanate and cefotaxime, ceftazidime,
cefpodoxime, or aztreonam disks (Nissui Pharmaceutical
Co., Ltd., Tokyo, Japan) as previously described [10].
Detection of b-lactamase genes was carried out by PCR
using primers for blaTEM, blaSHV and blaPSE-1 as described
previously [10]. Multiplex PCR was applied to the AmpC
genes, groups ACC, FOX, MOX, CIT and EBC, detection
as previously described [16]. As for samples positive for
CIT group, sequence analysis was performed using the pri-
mer pairs for amplification of the full-length gene of
blaCMY-2 [10]. Multiplex PCR was used for blaCTX-M
detection as previously described [17]. Subtypes of CTX-
M b-lactamases were determined using the primer pairs as
follows: CTX-MF (5’-GACTATTCATGTTGTTGT-
TATTTC-3’) and CTX-MR (5’-TTACAAACCGTTGGT-
GACG-3’) for CTX-M-group1 [18]; blaCTX-M-2F( 5 ’-
ATGATGACTCAGAGCATTCG-3’) and blaCTX-M-2R( 5 ’-
TCAGAAACCGTGGGTTACGA-3’) for CTX-M-group2
[10]; CTXM825F (5’-CGCTTTGCCATGTGCAGCACC-
3’) [19] and CTXM20 (5’-ATAACCGTCGGTGACAATT-
3’) [17] for CTX-M-group8 and 25/26. Nucleotide
sequences were preformed directly on both strands of
PCR products by using dye terminator chemistry. The
DNA alignments and deduced amino acid sequences were
examined using the BLAST program (National Center for
Biotechnology Information, USA).
The phylogenetic analysis revealed that 318 isolates of
E. coli from diseased animals were classified into four
phylogenetic groups (Table 1). The phylogenetic group
A was commonly predominant in isolates from cattle
(36/72, 50%) and pigs (101/157, 64.3%) whereas groups
A (44/89, 49.4%) and D (40/89, 44.9%) were predomi-
nant in isolates from poultry. The B2 group was rarely
found in E. coli from healthy cattle, chickens and pigs in
Brazil [3] as well as Japan. In Korea, group B2 was also
not found in E. coli isolates from food-producing ani-
mals [4]. These trends were similar to those of the pre-
sent study although clinical isolates from food-
producing animals were used here. On the other hand,
in the United States, groups A and D were predominant
(38% and 28%, respectively) in E. coli from diseased
poultry and group B2 was also found in 19% [6]. In Eur-
opean countries, group B2 was often isolated from dis-
eased poultry [7,8]. Thus, the distribution of
phylogenetic groups may be determined not only by the
animal species but also by their health status or geogra-
phical region.
Previous studies showed that the phylogenetic group
distribution may be related to antimicrobial resistance
prevalence in human isolates of E. coli [20]. In the pre-
sent study, 38 (11.9%) isolates exhibited CEZ resistance
(MIC: ≥32 μg/ml) (Table 2). Twenty-six (68.4%) of the
CEZ-resistant isolates belonged to group A. However,
rates of CEZ resistance among the phylogenetic groups,
except for group B2, were in 8.6-14.4%. Thus, no signifi-
cant difference in the resistance rates between the phy-
logenetic groups was observed.
Of the 38 resistant isolates, 11 isolates from two cattle
and nine poultry produced ESBLs while the remaining
27 isolates produced AmpC b-lactamase. The two
bovine isolates expressed blaCTX-M-2,w h i l e ,o ft h en i n e
poultry, four expressed blaCTX-M-25, three expressed
blaSHV-2, one expressed blaCTX-M-15 and one expressed
blaCTX-M-2.T h eblaTEM-1 gene, being non-ESBL, was
detected in 12 isolates. This is the first description of
the blaSHV-2, blaCTX-M-15 and blaCTX-M-25 enzymes in E.
coli from food-producing animals in Japan. In human
patients in Japan, E. coli strains carrying blaCTX-M-2 were
predominantly prevalent around 1997 [21], and then the
dominant b-lactamase type has changed to the CTX-M-
9 group, including blaCTX-M-14 and blaCTX-M-16,s i n c e
2001 [22]. As for food-producing animals, E. coli
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broilers [10] and cattle [11] in 2000 and pigs in 2003
[12]. In 2002, blaCTX-M-18, identical to amino acid
sequence of blaCTX-M-14, was identified in cephalos-
porin-resistant isolates from healthy broilers [10]. On
the other hand, of the remaining 27 AmpC b-lactamase
producing isolates, 13 isolates were PCR positive for
CIT group, being identified blaCMY-2: 10 from poultry,
t w of r o mc a t t l ea n do n ef r o ms w i n e( T a b l e2 ) .T h e r e
were no positive signals for group ACC, FOX, MOX
and EBC. The blaCMY-2 gene was found to be prevalent
in a wide range of food-producing animal species in
Japan [10,12], as well as other countries [23].
In the present study, 5 of 8 isolates producing CTX-M
ESBL and all three isolates producing SHV-type ESBL
belonged to group A. However, group B2 is predomi-
nant in SHV-type ESBL producing E. coli isolates of
human origin whereas group D is predominant in CTX-
M enzyme-producing isolates [24]. On the contrary, 7 of
13 isolates producing CMY-2 b-lactamase belonged to
group A. Group B1 was dominant in CMY enzyme-pro-
ducing E. coli from retail broiler meats [25]. It is likely
Table 1 Distribution of Escherichia coli isolate phylogenetic groups from diseased animals in Japan between 2001 and
2006
Phylogenetic group No. of isolates tested No. of isolates resistant to cefazolin (%)
Cattle Poultry Swine Total Cattle Poultry Swine Total
A 36 44 101 181 3 (8.3) 21 (47.7) 2 (2.0) 26 (14.4)
B1 18 4 9 31 2 (11.1) 1 (25.0) 0 (0) 3 (9.7)
B2 0 1 0 1 0 (NA) 0 (0) 0 (NA*) 0 (0)
D 18 40 47 105 1 (5.6) 7 (17.5) 1 (2.1) 9 (8.6)
Total 72 89 157 318 6 (8.3) 29 (32.6) 3 (1.9) 38 (11.9)
* NA: not applicable
Table 2 MICs of b-lactam antibiotics for 38 cefazolin-resistant isolates of E. coli from diseased animals isolated
between 2002 and 2006
MICs (μg/ml) of:
Animal
species
b-
lactamase
n Year
isolated
Phylogenetic
group
Cefazolin Cefpodoxime Cefotaxime Ceftazidime Aztreonam Imipenem Meropenem
(32)* (8) (64) (32) (32) (16) (16)
Cattle CTX-M-2 1 2003 (1) A (1) 256 >32 >32 4 16 ≤1 ≤4
CTX-M-2/
TEM-1
1 2003 (1) B1 (1) 256 >32 >32 8 >16 ≤1 ≤4
CMY-2 1 2003 (1) A (1) 256 8 ≤1 ≤1 ≤4 ≤1 ≤4
CMY-2/
TEM-1
1 2002 (1) D (1) 256 >32 8 16 ≤4 ≤1 ≤4
TEM-1 1 2003 (1) A (1) 32 8 ≤12 ≤4 ≤1 ≤4
ND 1 2002 (1) B1 (1) 128 16 ≤18 ≤4 ≤1 ≤4
Poultry CTX-M-2 1 2006 A (1) >512 >32 >32 2 ≤4 ≤1 ≤4
CTX-M-15/
TEM-1
1 2006 A (1) >512 >32 >32 32 8 ≤1 ≤4
CTX-M-25 4 2005(3),
2006 (1)
A (2), D (2) >512 >32 16->32 2-4 ≤4-8 ≤1 ≤4
SHV-2 3 2004 (3) A (3) 256-512 32->32 8-32 4-16 ≤4-8 ≤1 ≤4
CMY-2 10 2004(1),
2006
(10)
A (5), B1 (1), D
(5)
512->512 >32 4-32 8-32 ≤4-8 ≤1 ≤4
TEM-1 7 2004 (2),
2005 (5)
A (7) 64->512 16-32 ≤1-2 4-8 ≤4 ≤1 ≤4
ND 2 2002 (1),
2005 (1)
A (2) 128-256 16-32 ≤1-2 4 ≤4 ≤1 ≤4
Swine CMY-2/
TEM-1
1 2004 (1) A (1) >512 >32 16 32 16 ≤1 ≤4
ND 2 2002 (1),
2003 (1)
A (1), D (1) 128-256 4-8 ≤1 ≤1 ≤4 ≤1 ≤4
* Resistance breakpoint (μg/ml) defined by CLSI guideline.
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may be different between humans and food-producing
animals.
It is essential to understand the prevalence of resis-
tance to clinically important antimicrobials in bacteria
from food-producing animals. The MICs of six b-lactam
antibiotics are summarized in Table 2. All CEZ-resistant
isolates were susceptible to imipenem and meropenem.
All isolates exhibit cefpodoxime resistance (MIC of
breakpoint: ≥8 μg/ml) except for one porcine isolate in
which b-lactamase expression was not determined. All
isolates expressing CTX-M enzymes exhibit cefotaxime
resistance (MIC of breakpoint: ≥64 μg/ml) with the
exception of one poultry isolate (MIC: 16 μg/ml) har-
boring blaCTX-M-25. Resistance to ceftazidime was found
in three poultry and one porcine isolate with blaCMY-2,
and one poultry isolate with blaCTX-M-15.R e s i s t a n c et o
aztreonam was found in a single bovine isolate with
blaCTX-M-2. The MICs of antimicrobials tested varied in
isolates with each b-lactamase gene.
In conclusion, our study suggests that the distribution
of phylogenetic groups in E. coli from diseased domestic
animals varies regionally in addition to animal species.
Moreover, ESBL-producing E. coli from the animals
were frequently assigned to a specific group, being dif-
ferent from human ESBL isolates. Further study on
ESBL-producing E. coli f r o ms e v e r a la n i m a ls o u r c e s
using the PCR-based phylogenetic typing and the other
genotyping methods may clarify the relationship of the
resistant bacteria and/or the resistance determinants
prevalent in the food-chain and the environments.
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